Document Detail

Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
MedLine Citation:
PMID:  23205615     Owner:  NLM     Status:  Publisher    
This study evaluated the in vitro interaction between ciprofloxacin (CIP) and classical antifungals against Histoplasma capsulatum var. capsulatum in mycelial (n = 16) and yeast-like forms (n = 9) and Coccidioides posadasii in mycelial form (n = 16). This research was conducted through broth microdilution and macrodilution, according to Clinical Laboratory Standards Institute. Inocula were prepared to obtain from 0.5 × 10(3) to 2.5 × 10(4)  cfu ml(-1) for H. capsulatum and from 10(3) to 5 × 10(3)  cfu ml(-1) for C. posadasii. Initially, minimum inhibitory concentration (MIC) for each drug alone was determined. Then, these MICs were used as the highest concentration for each drug during combination assays. The procedures were performed in duplicate. For all combination assays, MICs were defined as the lowest concentration capable of inhibiting 80% of visible fungal growth, when compared to the drug-free control. Drug interaction was evaluated by paired sample t-Student test. The obtained data showed a significant MIC reduction for most tested combinations of CIP with antifungals, except for that of CIP and voriconazole against yeast-like H. capsulatum. This study brings potential alternatives for the treatment of histoplasmosis and coccidioidomycosis, raising the possibility of using CIP as an adjuvant antifungal therapy, providing perspectives to delineate in vivo studies.
R S N Brilhante; E P Caetano; J J C Sidrim; R A Cordeiro; Z P Camargo; M A B Fechine; R A C Lima; D S C M Castelo Branco; F J F Marques; J R L Mesquita; D T Lima; A J Monteiro; M F G Rocha
Related Documents :
24038465 - On the structural basis and design guidelines for type ii topoisomerase-targeting antic...
12446225 - Treatment options in pediatric epilepsy syndromes.
23445185 - Treatment of insomnia in older adults: re-evaluating the benefits and risks of sedative...
23316995 - Tubulin-targeting agent combination therapies: dosing schedule could matter.
17369105 - Recombination favors the evolution of drug resistance in hiv-1 during antiretroviral th...
24310425 - Factors and mechanisms for pharmacokinetic differences between pediatric population and...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-4
Journal Detail:
Title:  Mycoses     Volume:  -     ISSN:  1439-0507     ISO Abbreviation:  Mycoses     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8805008     Medline TA:  Mycoses     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Blackwell Verlag GmbH.
Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, Federal University of Ceará, Fortaleza, Brazil Postgraduate Program in Medical Sciences, Federal University of Ceará, Fortaleza, Brazil Department of Microbiology, Immunology and Parasitology, São Paulo Federal University, São Paulo, Brazil São José Hospital, Fortaleza, Brazil Department of Statistics and Applied Mathematics, Federal University of Ceará, Fortaleza, Brazil Postgraduate Program in Veterinary Sciences, State University of Ceará, Fortaleza, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pre-fractionation of Intact Proteins by Reversed-Phase and Anion-Exchange Chromatography for the Dif...
Next Document:  AD pathology and cerebral infarctions are associated with memory and executive functioning one and f...